Showing results (11-20 of 67) with videos related to
Sort By:
Pageof 7
Clinical and Experimental Obstetrics & Gynecology|April 12, 2000
Collection of fetal stem cells and newborn effectsC Pafumi, G Milone, A M Todaro, et al.Journal of Clinical Immunology|April 26, 2001
Fas-FasL in Hashimoto's thyroiditisG Stassi, A Zeuner, D Di Liberto, et al.Human Immunology|April 1, 1995
T-cell activation in HLA-B8, DR3-positive individuals. Early antigen expression defect in vitroG Candore, D Cigna, M Todaro, et al.European Journal of Immunology|April 1, 1994
Defective T cell receptor/CD3 complex signaling in human type I diabetesR De Maria, M Todaro, G Stassi, et al.Diabetologia|August 1, 1995
Low bcl-2 expression and increased spontaneous apoptosis in T-lymphocytes from newly-diagnosed IDDM patientsC Giordano, G Stassi, M Todaro, et al.Human Immunology|June 1, 1997
Defective expression of CD95 (FAS/APO-1) molecule suggests apoptosis impairment of T and B cells in HLA-B8, DR3-positive individualsG Stassi, M Todaro, R De Maria, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 14, 1999
Fas/Fas ligand-driven T cell apoptosis as a consequence of ineffective thyroid immunoprivilege in Hashimoto's thyroiditisG Stassi, M Todaro, F Bucchieri, et al.European Journal of Histochemistry : EJH|May 26, 1999
Defective apoptosis as potential mechanism in the tumorogenesis of myelolipomaF Cappello, F Farina, V Di Felice, et al.Annals of Hematology|December 2, 2000
Pregnancy outcome of a transfusion-dependent thalassemic womanC Pafumi, G Zizza, S Caruso, et al.Diabetologia|December 1, 1995
Defective expression of the apoptosis-inducing CD95 (Fas/APO-1) molecule on T and B cells in IDDMC Giordano, R De Maria, G Stassi, et al.Pageof 7